Search by Drug Name or NDC
NDC 10135-0735-60 PYRAZINAMIDE 500 mg/1 Details
PYRAZINAMIDE 500 mg/1
PYRAZINAMIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by MARLEX PHARMACEUTICALS, INC. The primary component is PYRAZINAMIDE.
MedlinePlus Drug Summary
Pyrazinamide kills or stops the growth of certain bacteria that cause tuberculosis (TB). It is used with other drugs to treat tuberculosis. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 10135-0735-60Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pyrazinamide
Product Information
| NDC | 10135-0735 |
|---|---|
| Product ID | 10135-735_0bb4d596-372c-8d6f-e063-6394a90acbad |
| Associated GPIs | 09000070000310 |
| GCN Sequence Number | 009424 |
| GCN Sequence Number Description | pyrazinamide TABLET 500 MG ORAL |
| HIC3 | W2E |
| HIC3 Description | ANTI-MYCOBACTERIUM AGENTS |
| GCN | 41790 |
| HICL Sequence Number | 004084 |
| HICL Sequence Number Description | PYRAZINAMIDE |
| Brand/Generic | Generic |
| Proprietary Name | PYRAZINAMIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | pyrazinamide tablet |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/1 |
| Substance Name | PYRAZINAMIDE |
| Labeler Name | MARLEX PHARMACEUTICALS, INC |
| Pharmaceutical Class | Antimycobacterial [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA080157 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 10135-0735-60 (10135073560)
| NDC Package Code | 10135-735-60 |
|---|---|
| Billing NDC | 10135073560 |
| Package | 60 TABLET in 1 BOTTLE (10135-735-60) |
| Marketing Start Date | 2022-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |